In addition, many nicely recognized adverse prognostic markers, which includes U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, lost their damaging outcome in patients handled with VO. The one factor that remained predictive of a shorter progression-cost-free survival During this cohort of patients was TP53 aberrations.112 Ultimately, the choice B